When does the patent expire on Wegovy?
Wegovy’s active ingredient is semaglutide. The exact patent-expiry date for “Wegovy” depends on which specific patent is being asked about (there are usually multiple patents covering different aspects such as the molecule, formulations, and manufacturing) and on the country/jurisdiction. Using a drug-patent tracking source, you can look up the relevant patent(s) and any listed expiry information for semaglutide/brand Wegovy on DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search “Wegovy” or “semaglutide” there).
What patents matter most for Wegovy (and why dates differ)?
Patent expiry is not one single date for a brand drug. For medicines like Wegovy, different patents can expire at different times, including:
- patents on the semaglutide molecule and its composition
- patents on specific formulations or dosing delivery approaches
- patents related to manufacturing processes
Those different patent sets can affect when generic or “biosimilar-style” competitors can launch, even if the earliest one has already ended.
Can competitors launch before all patents expire?
Yes. Even if some patents are still in force, competitors may be able to market their product once they can legally address the remaining protections (for example, via patent challenges/settlements or by waiting out the specific patents that block their path). The practical launch timing often follows the “last” relevant blocking patent, but market entry can be shaped by litigation and regulatory exclusivities too.
Which jurisdiction should you check (US, EU, UK, etc.)?
Patent timelines are jurisdiction-specific. If you tell me where you mean (for example, United States vs. European Union vs. UK), I can narrow down which patent set and expiry dates to look for on DrugPatentWatch.com and summarize the most relevant one(s).
Sources
- https://www.drugpatentwatch.com/